Introduction
Acquired immunodeficiency syndrome (AIDS) in adolescents was first documented, through retrospective diagnosis, in 1981.1 Within the adolescent population, the greatest legal barrier for minors in tenns of human immunodeficiency virus (HIV) testing is the parental consent rule. Traditionally, minors have been deemed incompetent to consent to their own medical care. The common law rule follows that consent of a minor's parent or guardian is generally required for medical care of the minor. Figure 1 .
Characteristics of minors visiting test sites and of minors tested for HIV antibodies are displayed in Table 1 . There was no significant difference in age between time 1 and time 2 in the group tested.
Testing of boys increased by 151%, while testing of girls increased by 90%. Similarly, in the total group of minors visiting test sites, the increase for boys (85%) at time 2 was nearly three times that for girls (32%). Of minors visiting test sites, the number identifying as White, non-Hispanic doubled at time 2, whereas the number identifying as Hispanic increased by slightly more than half and the number identifying as Black, non-Hispanic remained unchanged. Of minors tested for HIV, the number identifying as White, non-Hispanic increased twice as much (160%) as the number identifying as non-White (78%) at time 2.
In the total group visiting test sites, the number of minors at high risk (two or more risk factors) tripled from time 1 to time 2, while the number at low risk (one risk factor) remained essentially unchanged. The proportions tested increased at each risk factor level: in the one-riskfactor group, from 53% to 79%; in the two-risk-factor group, from 76% to 88%; and, in the three-or-more-risk-factor group, from 89% to 92%. The most frequently reported risk factors in both the total group and the tested subset were sex with a male, sex with a female, sexually transmitted disease diagnosis, and sex while using noninjecting drugs.
The test sites most frequently reported for the total group were sexually transmitted disease clinics, followed ferences exist between this sample and reported AIDS case patients, many of whom are in the hemophilia/coagulation disorder exposure category or are identifying as men who have sex with men. Neither exposure category was frequently reported in this sample. Among this sample of predominantly female minors, most testing in both groups took place at sexually transmitted disease and family planning clinics. Female minors are more likely to access these sites for other medical services. Many HIV test sites are at locations that traditionally provide other medical services. Adolescents' direct access of HIV test sites increased after removal of the parental consent requirement. It is unclear whether those test sites showing the greatest increases had other characteristics that may have attracted minors, such as accessible clinic hours or HIV counselors more familiar with the legislative change. This latter factor is poorly understood, because no systematic notification to counseling and testing providers took place when the legislative change went into effect (R. Melchreit, conversation, December 1996).
In addition to granting minors the right to consent to testing, the legislative change also allows access to treatment without the consent of a parent or guardian if such consent would jeopardize treatment. Adolescent-specific AIDS services, available in the state, could accommodate additional cases resulting from expanded testing given the low seroprevalence rate (0.1%) of this sample.
Because of the self-selection of minors seeking testing, this sample cannot be considered representative of the population of minors at risk for HIV infection in Connecticut. Variables other than the amended legislation, such as HIV education programs or media campaigns that may have influenced the minors' behaviors, were not assessed in this study. Furthermore, this investigation examined only those HIV test sites that received funding from the Connecticut Department of Public Health AIDS Division. In 1993, this funding accounted for approximately 25% of all HIV testing in the state. '4 Anyone who is at risk for HIV infection should be able to be tested. States that impose barriers to testing on minors (e.g., parental notification rules or difficult-to-interpret statutes) need to reexamine their efforts. HIV testing involves extensive counseling and prevention education by trained counselors.'5 Imposing barriers to HIV testing on minors not only hinders efforts to diagnose the disease and control the epidemic but fails to promote healthy behavior in an at-risk popula- smoking. '2-15 In this study, we examined how often community-based physicians in the state of California screen their adolescent patients for smoking. In addition, we hypothesized that screening for smoking would vary by specialty and physician's sex,1517 as well as by exposure to smoking-related diseases, both personally and in the practice setting, previous smoking-cessation training, attitudes towards adolescent patients, and attitudes about smoking cessation.6'1820
Methods

Physician Selection
We used a mailed questionnaire to survey a stratified (by specialty, geographic area, and sex) random sample of community-based, board-certified, specialists in pediatrics, family practice, and internal medicine or specialists in adolescent medicine (primarily pediatricians) who practice in California and spend at least 50% of their patient care time in primary care. Physicians who met study criteria were chosen randomly from the American Board of Medical Specialties Compendium ofCertified Medical Specialists. Adolescent medicine specialists were obtained from the membership roster of the Society for Adolescent Medicine or were identified as a member of the Section for Adolescent Health of the American Academy of Pediatrics; all adolescent medicine specialists were included in the study. The final sample included only physicians who graduated from medical
